Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621402 | SCV000736521 | likely benign | Cardiovascular phenotype | 2020-10-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000861131 | SCV001001359 | likely benign | Dilated cardiomyopathy 1KK | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293105 | SCV001434089 | likely benign | Hypertrophic cardiomyopathy | criteria provided, single submitter | research |